Evidence map›Paper›PMID 27500532›Full record

ArticleJournal of visualized experiments : JoVE2016

Identification of Rare Bacterial Pathogens by 16S rRNA Gene Sequencing and MALDI-TOF MS.

Percy Schröttner, Florian Gunzer, Jana Schüppel, Wolfram W Rudolph

Abstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Comprehensive Phenotypic Characterization of ClinicalInternational journal of molecular sciences · 2026
    Article
  2. Article
  3. Microorganisms · 2025
    Review
  4. Microorganisms · 2025
    Review
  5. Microorganisms · 2025
    Review
  6. Review
  7. Article
  8. Review
  9. Expression profiles of sporulation genes in multidrug-resistantExperimental biology and medicine (Maywood, N.J.) · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Identification and Antibiotic Profiling ofFrontiers in microbiology · 2021
    Article
  16. Article
  17. Article
  18. A case ofJMM case reports · 2017
    Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Percy SchröttnerInstitut für Medizinische Mikrobiologie und Hygiene, Medizinische Fakultät Carl Gustav Carus, TU Dresden; percy.schroettner@tu-dresden.de.
Florian GunzerInstitut für Medizinische Mikrobiologie und Hygiene, Medizinische Fakultät Carl Gustav Carus, TU Dresden.
Jana SchüppelInstitut für Virologie, Medizinische Fakultät Carl Gustav Carus, TU Dresden.
Wolfram W RudolphInstitut für Virologie, Medizinische Fakultät Carl Gustav Carus, TU Dresden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are a number of rare and, therefore, insufficiently described bacterial pathogens which are reported to cause severe infections especially in immunocompromised patients. In most cases only few data, mostly published as case reports, are available which investigate the role of such pathogens as an infectious agent. Therefore, in order to clarify the pathogenic character of such microorganisms, it is necessary to conduct epidemiologic studies which include large numbers of these bacteria. The methods used in such a surveillance study have to meet the following criteria: the identification of the strains has to be accurate according to the valid nomenclature, they should be easy to handle (robustness), economical in routine diagnostics and they have to generate comparable results among different laboratories. Generally, there are three strategies for identifying bacterial strains in a routine setting: 1) phenotypic identification characterizing the biochemical and metabolic properties of the bacteria, 2) molecular techniques such as 16S rRNA gene sequencing and 3) mass spectrometry as a novel proteome based approach. Since mass spectrometry and molecular approaches are the most promising tools for identifying a large variety of bacterial species, these two methods are described. Advances, limitations and potential problems when using these techniques are discussed.

Indexed as

Spectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationBacteriaBacterial InfectionsHumansProteomicsRNA, Ribosomal, 16SRNA, Ribosomal, 16S

Identifiers

PMID27500532
PMCPMC4993432

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.